New Tool in Development to Assess Geriatric Cancer Pain [Annual Symposium on Advances in Pain Research] Eastman, Peggy BETHESDA, MD-As the population ages and the number of older people living with cancer increases, so too will the number of older people living with cancer pain, necessitating new...
Big Pharma Is in a Frenzy to Bring Cannabis-Based The US government's longstanding denial of medical marijuana research and use is an irrational and morally bankrupt public policy.On this point, few Americans disagree.
As for the question of 'why' federal officials maintain this...
Web: Big Pharma Is in a Frenzy to Bring Cannabis-Based BIG PHARMA IS IN A FRENZY TO BRING CANNABIS-BASED MEDICINES TO MARKET The US government's longstanding denial of medical marijuana research and use is an irrational and morally bankrupt public policy.On this point, few Americans disagree....
Big Pharma Is in a Frenzy to Bring Cannabis-Based Medicines to Market While the the American Medical Association claims pot has no medical value, Big Pharma is busy getting patents for marijuana products.Tools Share and save this post: Also in DrugReporter Bruce Mirken David Borden Amy Turner Jennifer Kern...
Par Pharma gets US FDA marketing nod for generic Marinol Par Pharmaceutical Companies, Inc.has received final approval from the US Food and Drug Administration for its Abbreviated New Drug Application for dronabinol, a generic version of Solvay Pharmaceutical's Marinol, a CIII controlled...
Watson launches generic Marinol capsules Watson Pharmaceuticals, Inc.(WPI), a leading specialty pharmaceutical company, announced that, under a supply agreement with Solvay Pharmaceuticals, Inc., Watson has launched the authorized generic version of dronabinol in the 2.5, 5 and...
Par Pharmaceuticals Gets FDA Approval For Generic Chemotherapy Side Effect Treatment (FinancialWire) Par Pharmaceutical Cos.(NYSE: PRX) has received approval from the Food and Drug Administration for its generic version of Solvay Pharmaceutical's chemotherapy side effect treatment.
The drug, called Marinol, is...
Watson Pharmaceuticals Inc ships generic MARINOL capsules Watson Pharmaceuticals Inc (NYSE: WPI), a speciality pharmaceutical company, said on 30 June that the company has entered into a supply agreement with Solvay Pharmaceuticals Inc for the former's generic dronabinol in the 2.5, 5 and 10 mg...
Watson introduces generic Marinol capsules Dronabinol is the generic version of Solvay Pharmaceuticals's Marinol CIII capsules, indicated to treat nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional...
Par Pharmaceutical Receives Final Approval to Market Generic Marinol(R) CIII (Dronabinol) Capsules Par to Begin Shipping Dronabinol Soft Gel Capsules Immediately WOODCLIFF LAKE, N.J., June 30 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc.today announced that it has received final approval from the U.S.
Food and Drug...
Par Pharmaceutical Receives Final Approval to Market Generic Marinol(R) CIII (Dronabinol) Capsules Par to Begin Shipping Dronabinol Soft Gel Capsules Immediately WOODCLIFF LAKE, N.J., June 30 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc.today announced that it has received final approval from the U.S.
Food and Drug...
Generic Version of Marinol Launched but forget your password, you can request it be sent to you by email.Generic Version of Marinol Launched.
Par Pharmaceutical shares rise on FDA approval for generic chemotherapy side effect drug - 8:10 p.m.NEW YORK (AP) - Par Pharmaceutical Cos.
shares rose Monday after the company said the Food and Drug Administration approved its generic version of Solvay Pharmaceutical's chemotherapy side effect treatment.
Shares of...
Par Pharmaceutical Receives Final Approval to Market Generic Marinol(R) CIII (Dronabinol) Capsules Par to Begin Shipping Dronabinol Soft Gel Capsules Immediately WOODCLIFF LAKE, N.J., June 30 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc.today announced that it has received final approval from the U.S.
Food and Drug...
Par Pharmaceutical gets Final Approval to Market Generic Marinol CIII Capsules - Quick Facts (RTTNews) - Par Pharmaceutical Companies Inc.(PRX: News, Chart, Quote ) announced that it has received final approval from the U.S.
Food and Drug Administration for its Abbreviated New Drug Application for dronabinol, a generic version...
Par Pharma gets final FDA approval to market generic Marinol SAN FRANCISCO (Thomson Financial) - Par Pharmaceutical Cos.said Monday it has received final approval from the Food and Drug Administration to market dronabinol, a generic version of Solvay Pharmaceutical's Marinol, for the...
Par Pharma gets final FDA approval to market generic Marinol SAN FRANCISCO (Thomson Financial) - Par Pharmaceutical Cos.(News) said Monday it has received final approval from the Food and Drug Administration to market dronabinol, a generic version of Solvay Pharmaceutical's Marinol, for the...
Par Pharma gets final FDA approval to market generic Marinol SAN FRANCISCO (Thomson Financial) - Par Pharmaceutical Cos.said Monday it has received final approval from the Food and Drug Administration to market dronabinol, a generic version of Solvay Pharmaceutical's Marinol, for the...
Par Pharmaceutical (PRX) Receives FDA Approval for Generic Marinol Par Pharmaceutical Companies, Inc.(NYSE: PRX) has received final approval from the U.S.
Food and Drug Administration (FDA) for its Abbreviated New Drug Application for dronabinol, a generic version of Solvay Pharmaceutical's Marinol, ...
Watson Pharma launches generic nausea drug Branded and generic drug maker Watson Pharmaceutical Inc.said Monday it launched a generic version of Solvay SA's Marinol, which treats chemotherapy-induced nausea.
Marinol is also approved to treat anorexia associated with...
Watson Pharma launches generic nausea drug CORONA, Calif.- Branded and generic drug maker Watson Pharmaceutical Inc.
said Monday it launched a generic version of Solvay SA's Marinol, which treats chemotherapy-induced nausea.
Marinol is also approved to treat...
Par Pharmaceutical Receives Final Approval to Market Generic Marinol CIII (Dronabinol) Capsules Par to Begin Shipping Dronabinol Soft Gel Capsules Immediately WOODCLIFF LAKE, N.J., June 30, 2008 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc.today announced that it has received final approval from the U.S.
Food and...
Par Pharmaceutical Receives Final Approval to Market Generic Marinol(R) CIII (Dronabinol) Capsules WOODCLIFF LAKE, N.J., June 30 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc.(NYSE: PRX - News) today announced that it has received final approval from the U.S.
Food and Drug Administration for its Abbreviated New Drug...
Watson Pharmaceuticals launches generic version of dronabinol Watson Pharmaceuticals, Inc.has announced that, under a supply agreement with Solvay Pharmaceuticals, Inc., Watson has launched the authorized generic version of dronabinol in the 2.5, 5 and 10 mg once daily dosage strengths.Dronabinol is...
Par Pharma gets final FDA approval to market generic Marinol Annual U.S.sales of Marinol are roughly $190 million, Par said, citing IMS Health data.
The Woodcliff, N.J.-based company will begin shipping all strengths of dronabinol soft gel capsules immediately.
Under the terms of an...
